Maple Rock Capital Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43M Sell
603,303
-71,413
-11% -$4.88M 1.4% 24
2025
Q4
$39.9M Hold
674,716
1.32% 25
2025
Q3
$37.2M Buy
674,716
+21,200
+3% +$1.1M 1.47% 27
2025
Q2
$28.2M Buy
653,516
+116,700
+22% +$4.5M 1.38% 28
2025
Q1
$21.3M Buy
536,816
+107,000
+25% +$4.74M 0.78% 31
2024
Q4
$17.5M Buy
+429,816
New +$17.9M 0.53% 32
2023
Q2
Sell
-545,300
Closed -$39M 25
2023
Q1
$39M Sell
545,300
-145,000
-21% -$11.5M 3.44% 11
2022
Q4
$48.6M Sell
690,300
-220,800
-24% -$15.6M 1.97% 10
2022
Q3
$55.2M Sell
911,100
-33,400
-4% -$2.24M 2.64% 16
2022
Q2
$59.6M Buy
944,500
+147,000
+18% +$9.58M 3.48% 9
2022
Q1
$51.1M Sell
797,500
-7,500
-0.9% -$502K 2.73% 13
2021
Q4
$57.7M Buy
805,000
+95,020
+13% +$7.23M 6.16% 5
2021
Q3
$50.7M Hold
709,980
7.1% 6
2021
Q2
$57.8M Buy
709,980
+267,400
+60% +$21.5M 8.68% 4
2021
Q1
$33.4M Sell
442,580
-42,420
-9% -$3.09M 4.85% 6
2020
Q4
$36.7M Sell
485,000
-214,000
-31% -$13.9M 5.33% 6
2020
Q3
$34.6M Sell
699,000
-70,345
-9% -$3.97M 6.31% 4
2020
Q2
$40.4M Sell
769,345
-65,011
-8% -$3.09M 8.09% 2
2020
Q1
$29.4M Buy
+834,356
New +$48.7M 7.53% 3
2017
Q3
Sell
-40,100
Closed -$2.3M 18
2017
Q2
$2.3M Sell
40,100
-445,721
-92% -$26.2M 0.71% 18
2017
Q1
$29.6M Sell
485,821
-5,000
-1% -$283K 6.07% 5
2016
Q4
$26.9M Buy
490,821
+190,700
+64% +$9.15M 9.06% 4
2016
Q3
$13.8M Buy
300,121
+120,000
+67% +$5.07M 5.24% 9
2016
Q2
$6.13M Buy
+180,121
New +$5.62M 2.88% 15

Other funds holding NGVT

Maple Rock Capital Partners's NGVT Position: Q1 2026 in Review

Maple Rock Capital Partners reduced its Ingevity (NGVT) stake by 11% in Q1 2026, selling an estimated $4.88M and leaving 603,303 shares worth $43M. The position accounts for 1.4% of the portfolio, ranked #24.

Maple Rock Capital Partners first reported a position in NGVT in Q2 2016 and has held it in 24 quarters since. The position peaked at $59.6M in Q2 2022. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Maple Rock Capital Partners held 603,303 shares of Ingevity worth $43M as of Q1 2026.
  • Maple Rock Capital Partners sold 71,413 Ingevity shares in Q1 2026, an estimated $4.88M.
  • Ingevity made up 1.4% of Maple Rock Capital Partners's portfolio in Q1 2026, its #24 holding.
  • Maple Rock Capital Partners first reported a position in Ingevity in Q2 2016 and has held it in 24 quarters since.
  • Maple Rock Capital Partners's Ingevity position peaked at $59.6M in Q2 2022.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Maple Rock Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.